Colgate-Palmolive (NYSE:CL) Shares Sold by BBR Partners LLC

BBR Partners LLC lessened its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 60.5% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,353 shares of the company’s stock after selling 3,597 shares during the quarter. BBR Partners LLC’s holdings in Colgate-Palmolive were worth $214,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of the business. West Family Investments Inc. grew its holdings in Colgate-Palmolive by 10.9% during the 4th quarter. West Family Investments Inc. now owns 6,309 shares of the company’s stock valued at $574,000 after purchasing an additional 622 shares in the last quarter. Ashton Thomas Private Wealth LLC grew its stake in shares of Colgate-Palmolive by 5.9% during the fourth quarter. Ashton Thomas Private Wealth LLC now owns 15,452 shares of the company’s stock valued at $1,405,000 after acquiring an additional 863 shares in the last quarter. Callan Family Office LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at about $614,000. EagleClaw Capital Managment LLC lifted its stake in shares of Colgate-Palmolive by 6.2% in the fourth quarter. EagleClaw Capital Managment LLC now owns 34,914 shares of the company’s stock worth $3,174,000 after acquiring an additional 2,035 shares in the last quarter. Finally, Candriam S.C.A. boosted its holdings in Colgate-Palmolive by 26.0% in the fourth quarter. Candriam S.C.A. now owns 349,673 shares of the company’s stock valued at $31,789,000 after purchasing an additional 72,175 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent analyst reports. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday, February 3rd. UBS Group decreased their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, Morgan Stanley cut their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Up 3.8 %

Shares of NYSE:CL opened at $96.84 on Friday. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The company has a market cap of $78.59 billion, a PE ratio of 27.51, a P/E/G ratio of 4.20 and a beta of 0.40. The company’s 50-day moving average price is $88.84 and its 200 day moving average price is $95.22.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company posted $0.87 EPS. Sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.07%. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.